v3.26.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 181,174 $ 105,525
Restricted cash 77,182 93,409
Loans receivable at fair value 2,795,455 2,874,092
Capitalized software and other intangibles, net 64,200 71,698
Right of use assets - operating 10,663 9,441
Other assets 85,105 103,691
Total assets 3,213,779 3,257,856
Liabilities    
Secured financing 449,718 199,384
Asset-backed notes at fair value 93,464 263,799
Asset-backed borrowings at amortized cost 2,039,004 2,192,649
Corporate financing 121,151 143,663
Lease liabilities 11,319 11,468
Other liabilities 65,684 56,811
Total liabilities 2,780,340 2,867,774
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at September 30, 2026 and December 31, 2025; 46,351,842 shares issued and 46,079,819 shares outstanding at September 30, 2026; 44,709,065 shares issued and 44,437,042 shares outstanding at December 31, 2025 8 8
Common stock, additional paid-in capital 633,213 623,668
Accumulated deficit (193,473) (227,285)
Treasury stock at cost, 272,023 shares at September 30, 2026 and December 31, 2025 (6,309) (6,309)
Total stockholders’ equity 433,439 390,082
Total liabilities and stockholders' equity $ 3,213,779 $ 3,257,856

Source

HTML PDF
XBRL
ZIP